The U.S. Environmental Protection Agency (EPA) stated Thursday it completed a regulatory review that discovered glyphosate, a widely used weed killer in the U.S., is not a carcinogen.
The outcome reaffirms the EPA’s stand on glyphosate, the vital ingredient in Bayer AG’s Roundup, despite orders by U.S. juries that have discovered that use of the weedkiller was responsible for plaintiffs’ cancer in some trials.
The EPA judgment could assist in bolstering the case for Bayer as it faces thousands of more suits from Roundup users who allege it inflicted their cancer.
Bayer, which purchased Roundup manufacturer Monsanto for $63 billion two years ago, embraced the conclusions. The firm has maintained glyphosate and Roundup are safe and not carcinogenic.
Farmers spray glyphosate on fields of soybeans and several other crops. Roundup is also utilized on lawns and golf courses.
In 2015, WHO’s cancer unit categorized glyphosate as “probably carcinogenic to humans.”
Bayer stated last Friday it reached a settlement with plaintiffs’ lawyers to delay a Missouri jury trial over accusations Roundup causes cancer to give time for meetings to settle the case.
Three consecutive juries previously found Bayer responsible for causing most cancers with damages of thousands of dollars awarded to each plaintiff. The firm is challenging those verdicts.
Bayer is contemplating stopping sales of glyphosate to private users who apply it in their gardens as a part of settlement discussions with U.S. plaintiffs.